Patents by Inventor Gilles Feutren

Gilles Feutren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of S1P Receptor Agonists in Heart Diseases
    Publication number: 20110136739
    Abstract: The invention relates to the use of sphingosine-1-phosphate receptor agonist in the treatment of heart diseases.
    Type: Application
    Filed: February 8, 2011
    Publication date: June 9, 2011
    Inventors: Volker BRINKMANN, Gilles FEUTREN, Robert Paul HOF
  • Use of S1P receptor agonists in heart diseases
    Patent number: 7910626
    Abstract: The invention relates to the use of a sphingosine-1-phosphate receptor agonist in the treatment of heart diseases.
    Type: Grant
    Filed: October 2, 2008
    Date of Patent: March 22, 2011
    Assignee: Novartis AG
    Inventors: Volker Brinkmann, Gilles Feutren, Robert Paul Hof
  • Treatment of HCV Disorders
    Publication number: 20100317627
    Abstract: S1P receptor agonists are useful for the treatment of hepatitis C or chronic hepatitis C (HCV).
    Type: Application
    Filed: August 19, 2010
    Publication date: December 16, 2010
    Inventors: Volker BRINKMANN, Gilles FEUTREN
  • Use of S1P receptor agonists in heart diseases
    Publication number: 20090029922
    Abstract: The invention relates to the use of a sphingosine-1-phosphate receptor agonist in the treatment of heart diseases.
    Type: Application
    Filed: October 2, 2008
    Publication date: January 29, 2009
    Inventors: Volker Brinkmann, Gilles Feutren, Robert Paul Hof
  • CD25 BINDING MOLECULES FOR THE USE IN THE TREATMENT OF MANIFESTATIONS OF REJECTION IN TRANSPLANTATION
    Publication number: 20080286281
    Abstract: Administration of monoclonal antibodies specific for IL-2R to xenograft recipients, or long-term to immunosuppression-intolerant or non-compliant patients over a period of time beyond the very early phase of organ transplantation, prevents transplant rejection.
    Type: Application
    Filed: July 28, 2008
    Publication date: November 20, 2008
    Inventors: Gilles Feutren, Richard Kimberley Howell, Peter Marbach, Andrew Roberts, Max H. Schreier, Karin Schreier, Daniel Mark Schreier, Anja Bettina Schreier, Manfred Schulz
  • Treatment of Hcv Disorders
    Publication number: 20080207567
    Abstract: S1P receptor agonists are useful for the treatment of hepatitis C or chronic hepatitis C (HCV).
    Type: Application
    Filed: January 2, 2006
    Publication date: August 28, 2008
    Inventors: Volker Brinkmann, Gilles Feutren
  • Pharmaceutical multiparticulate composition comprising mycophenolic acid or mycophenolate sodium and combination with rapamycin
    Publication number: 20070036857
    Abstract: The present invention relates to a novel composition of mycophenolic acid, a salt or a prodrug thereof and to a fixed combination of mycophenolic acid, a salt or a prodrug thereof and rapamycin or a rapamycin derivative.
    Type: Application
    Filed: October 1, 2004
    Publication date: February 15, 2007
    Inventors: Dieter Becker, Carsten Burger, Gilles Feutren, Patrice Guitard, Andrea Kramer, Nicoletta Loggia, Christian-Peter Luftensteiner, Jorg Ogorka, Harald Ottinger
  • Use of s1p receptor agonists in heart diseases
    Publication number: 20050222092
    Abstract: The invention relates to the use of a sphingosine-1-phosphate receptor agonist in the treatment of heart diseases.
    Type: Application
    Filed: July 23, 2003
    Publication date: October 6, 2005
    Inventors: Volker Brinkmann, Gilles Feutren, Robert Hof
  • CD25 binding molecules for use in the treatment of manifestations of rejection in transplantation
    Publication number: 20010041179
    Abstract: Administration of monoclonal antibodies specific for IL-2R to xenograft recipients, or long-term to immunosuppression-intolerant or non-compliant patients over a period of time beyond the very early phase of organ transplantation, prevents transplant rejection.
    Type: Application
    Filed: May 22, 2001
    Publication date: November 15, 2001
    Inventors: Gilles Feutren, Richard Kimberley Howell, Peter Marbach, Andrew Roberts, Max H. Schreier, Karin Schreier, Daniel Mark Schreier, Anja Bettina Schreier, Manfred Schulz